A nurse is assessing a client who has Lewy body dementia. The nurse should recognize that which of the following is responsible for changes in thinking, communication, movement, and emotional processing in Lewy body dementia?

A. Lisinopril: Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor commonly used to treat hypertension and heart failure. It is not typically contraindicated for cataract extraction surgery, and it does not significantly increase the risk of bleeding.

B. Synthroid: Synthroid is a synthetic form of thyroid hormone used to treat hypothyroidism. It does not have any direct contraindications with cataract extraction surgery and does not significantly increase the risk of bleeding.

C. Clopidogrel: Clopidogrel is an antiplatelet medication commonly used to prevent blood clots in individuals with cardiovascular diseases such as coronary artery disease or recent myocardial infarction. However, it can increase the risk of bleeding, which may be problematic during cataract extraction surgery. Therefore, it is important to question administering clopidogrel prior to the procedure and potentially coordinate with the healthcare provider regarding its management.

D. Omeprazole: Omeprazole is a proton pump inhibitor used to reduce stomach acid production and treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcer disease. It does not have any direct contraindications with cataract extraction surgery and does not significantly increase the risk of bleeding.

A. Tau protein: Tau protein is primarily associated with Alzheimer's disease and other tauopathies, not Lewy body dementia.

B. Neurofibrillary tangles: Neurofibrillary tangles are aggregates of hyperphosphorylated tau protein found in Alzheimer's disease, not typically in Lewy body dementia.

C. Alpha-synuclein protein: Lewy bodies, which are abnormal aggregates of alpha-synuclein protein, are a hallmark pathology of Lewy body dementia. These protein aggregates disrupt neuronal function and are responsible for the cognitive, motor, and emotional symptoms seen in Lewy body dementia.

D. Beta-amyloid protein: Beta-amyloid protein is primarily associated with Alzheimer's disease, not Lewy body dementia. It forms plaques in the brain, which contribute to neurodegeneration and cognitive decline in Alzheimer's disease.